Dr Burke on Ongoing Investigations of Targeted Therapy Regimens in MCL
John M. Burke, MD, discusses several ongoing or upcoming investigations of targeted therapy in mantle cell lymphoma.
Source: onclive.com
Hematology Research Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematology Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematology Research Program Today - Breaking & Trending Today
New and Anticipated Advances Across Hematologic Malignancies Necessitate Improved Navigation of Current Options
John M. Burke, MD, expands on the use of novel BTK inhibitor regimens in mantle cell lymphoma, treatment sequencing challenges and other unmet needs in diffuse-large B-cell lymphoma, the evolution of management strategies for myeloproliferative neoplasms, and the potential influence of new and emerging therapeutics in chronic lymphocytic leukemia.
Source: onclive.com
Dr Burke on the Influence of the SHINE and TRIANGLE Trials on Ibrutinib Use in MCL
John M. Burke, MD, discusses the influence of two key BTK inhibitor combination studies on therapeutic approaches for patients with previously untreated mantle cell lymphoma.
Source: onclive.com